history of orkambi

HISTORY OF ORKAMBI®

2015

ORKAMBI was approved to treat people with CF age 12 and older who have 2 copies of the F508del mutation.

2016

ORKAMBI was approved to treat children age 6 through 11 years who have 2 copies of the F508del mutation, based on additional safety studies.

2018

ORKAMBI was approved to treat children age 2 through 5 years who have 2 copies of the F508del mutation, based on additional safety studies.